WHO ICTRP trial
EWALL-PH-03: An open label, 2-arm, Randomised phase II study to Compare the…
CTIS2023-505330-95-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-505330-95-01 |
|---|---|
| Public title | EWALL-PH-03: An open label, 2-arm, Randomised phase II study to Compare the Safety and Efficacy of Ponatinib plus Chemotherapy with Imatinib plus Chemotherapy as front-line therapy for patients aged 55 years and over with Philadelphia chromosome positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL) |
| Scientific title | EWALL-PH-03: An open label, 2-arm, Randomised phase II study to Compare the Safety and Efficacy of Ponatinib plus Chemotherapy with Imatinib plus Chemotherapy as front-line therapy for patients aged 55 years and over with Philadelphia chromosome positive (Ph+ or BCR-ABL+) Acute Lymphoblastic… |
| Primary sponsor | Cardiff University |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Sweden;Finland;France |
| Conditions | Blood cancer MedDRA version: 21.0Level: LLTClassification code: 10000845Term: Acute lymphoblastic leukemia Class: 10029104;Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15] |
| Interventions | Product Name: Iclusig 15 mg film-coated tablets, Product Code:PRD4563018, Pharmaceutical Form: FILM-COATED TABLET, Other descriptive name: , Strength: , Product Name: BLINCYTO 38.5 micrograms powder for concentrate and solution for solution… |
| Registration date | Jan 16, 2025 |
| Target size | 100 |
| Secondary IDs | NCT04688983;2018-003350-25 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: